Amenis Bioscience Inc. has identified anthranilic acid derivatives acting as peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) and viral replication inhibitors reported to be useful for ...

ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA ...

Infection with cytomegalovirus (CMV) is extremely common, but the virus only becomes pathogenic when the immune system is weakened, by, for example, HIV or anti-rejection transplant immunosupressors.

National Science & Technology Development Agency (NSTDA) has described cordycepin derivatives acting as viral replication inhibitors reported to be useful for the treatment of viral infections.

Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

For the first time, scientists have captured how new antiviral drugs halt the herpes virus in real time as it tries to replicate.

The clinical development pathway is currently dominated by ARV agents [3] and includes a clinical trial to confirm the CAPRISA 004 trial findings; testing of new ARV agents, different formulations and ...